These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38606836)
61. Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections. Schweizer ML; Richardson K; Vaughan Sarrazin MS; Goto M; Livorsi DJ; Nair R; Alexander B; Beck BF; Jones MP; Puig-Asensio M; Suh D; Ohl M; Perencevich EN Clin Infect Dis; 2021 Jan; 72(Suppl 1):S68-S73. PubMed ID: 33512521 [TBL] [Abstract][Full Text] [Related]
62. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623 [TBL] [Abstract][Full Text] [Related]
63. Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System. Mootz ML; Britt RS; Mootz AA; Lee GC; Reveles KR; Evoy KE; Teng C; Frei CR Hosp Pract (1995); 2019 Oct; 47(4):186-191. PubMed ID: 31578888 [No Abstract] [Full Text] [Related]
65. Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Kebriaei R; Rice SA; Stamper KC; Rybak MJ Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670436 [TBL] [Abstract][Full Text] [Related]
66. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355 [TBL] [Abstract][Full Text] [Related]
67. Ceftaroline Fosamil as an Alternative for a Severe Methicillin-resistant Staphylococcus aureus Infection: A Case Report. Jilani TN; Masood SO Cureus; 2018 Dec; 10(12):e3776. PubMed ID: 30820395 [TBL] [Abstract][Full Text] [Related]
68. Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature. Baxi SM; Chan D; Jain V Infection; 2015 Dec; 43(6):751-4. PubMed ID: 25805524 [TBL] [Abstract][Full Text] [Related]
69. Septic Thrombophlebitis with Persistent Methicillin-Resistant Koton Y; Or Z; Bisharat N Infect Dis Rep; 2017 May; 9(2):7008. PubMed ID: 28626538 [TBL] [Abstract][Full Text] [Related]
70. Vancomycin plus nafcillin salvage for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia following daptomycin failure: a case report and literature review. Lewis PO; Sevinsky RE; Patel PD; Krolikowski MR; Cluck DB Ther Adv Infect Dis; 2019; 6():2049936118797404. PubMed ID: 30891239 [TBL] [Abstract][Full Text] [Related]
71. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections. Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316 [TBL] [Abstract][Full Text] [Related]
72. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707 [TBL] [Abstract][Full Text] [Related]
73. Pre-clinical Impact of the Synergistic Mechanism of Daptomycin and Ceftaroline on Patients with Methicillin-resistant Staphylococcus aureus Bacteremia Infections. Eliazar J; Johnson T; Chbib C Curr Rev Clin Exp Pharmacol; 2021; 16(4):296-299. PubMed ID: 33423652 [TBL] [Abstract][Full Text] [Related]
74. National surveillance of antimicrobial susceptibilities to ceftaroline, dalbavancin, telavancin, tedizolid, eravacycline, omadacycline, and other comparator antibiotics, and genetic characteristics of bacteremic Staphylococcus aureus isolates in adults: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) program in 2020. Chen CH; Wu PH; Lu MC; Ho MW; Hsueh PR; Int J Antimicrob Agents; 2023 Apr; 61(4):106745. PubMed ID: 36758774 [TBL] [Abstract][Full Text] [Related]
75. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. Smith JR; Yim J; Raut A; Rybak MJ Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159 [TBL] [Abstract][Full Text] [Related]
76. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. Haynes AS; Maples H; Parker S J Pediatric Infect Dis Soc; 2023 May; 12(5):308-318. PubMed ID: 37144953 [TBL] [Abstract][Full Text] [Related]
77. A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant Lounsbury N; Reeber MG; Mina G; Chbib C Antibiotics (Basel); 2019 Mar; 8(1):. PubMed ID: 30897759 [TBL] [Abstract][Full Text] [Related]
78. The efficacy of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bloodstream infection in patients with impaired renal function. Weston A; Golan Y; Holcroft C; Snydman DR Clin Infect Dis; 2014 Jun; 58(11):1533-9. PubMed ID: 24642554 [TBL] [Abstract][Full Text] [Related]
79. Ceftaroline for Severe Methicillin-Resistant Cosimi RA; Beik N; Kubiak DW; Johnson JA Open Forum Infect Dis; 2017; 4(2):ofx084. PubMed ID: 28702467 [TBL] [Abstract][Full Text] [Related]
80. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Vidaillac C; Leonard SN; Rybak MJ Int J Antimicrob Agents; 2010 Jun; 35(6):527-30. PubMed ID: 20346632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]